2021 Archived Content

Conference Programs

September 28-29

PRESENTED IN-PERSON & VIRTUALLY

Target Identification and Validation – Part 1

RNA as a Drug Target

PROTACs and Targeted Protein Degradation – Part 1

Antibodies Against Membrane Protein Targets – Part 1

GPCR-Based Drug Discovery

PRESENTED VIRTUALLY

3D Cellular Models

Immunology and Oncology: Emerging Drug Targets

September 29-30

PRESENTED IN-PERSON & VIRTUALLY

Target Identification and Validation – Part 2

Lead Generation Strategies

PROTACs and Targeted Protein Degradation – Part 2

Antibodies Against Membrane Protein Targets – Part 2

NASH and Fibrosis

PRESENTED VIRTUALLY

Small G Proteins

Preclinical Strategies and Models in Oncology

Premier & Corporate Sponsors

View All
Sponsors

2021 Event Available On-Demand

Access Discovery On Target presentations you missed in 2021

PURCHASE ON-DEMAND

2021 Plenary Keynote Speakers:

G Protein-Coupled Receptors and Beta Arrestin-Coupled Receptors: A Tale of Two Transducers

Robert J. Lefkowitz, MD
James B. Duke Professor of Medicine, Professor of Biochemistry, Duke University Medical Center; Investigator, Howard Hughes Medical Institute

Next-Generation Targeted Molecular Therapies

Alexandra Glucksmann, PhD
President & CEO, Cedilla Therapeutics

Register with Confidence

Your safety and comfort are our priority. To provide maximum flexibility to match your needs, CHI provides this event as both an in-person and virtual experience. We feel the combination of these two experiences will bring about a truly unique event. This new conference norm will fuse the best of our traditional onsite events with the expanded benefits of a virtual conference. Bringing together the life sciences community is what CHI does, and we look forward to bringing our community together with this new offering.

Flexible Registration – Seamlessly switch between In-Person and/or Virtual

Select an in-person or virtual option, and you have the flexibility to switch your preferred event experience at any time leading up to the conference. Simply contact us, and we will either charge you the difference for upgrading to in-person or credit back the price for transferring to virtual. Our flexible registration is designed to take the uncertainties out of these uncertain times.

The Discovery on Target Community Reconnects in 2021!

Discovery on Target (DOT) is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. DOT highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

We aim to meet your research needs. Delegates can visit numerous concurrent sessions in-person and virtually and – with on-demand access to presentations – benefit even from those you can’t attend live. You can customize your experience further through focused short courses, interactive discussions, and networking options that help you engage with experts and solutions providers onsite, or from the comfort of home!

2021 Event Features

10 Conferences presented both in-person and virtually and 4 Conferences presented virtually only

Concurrent Conference Talks live onsite, remotely, or on-demand: Register for one track and “hop” to and benefit from parallel presentations you can’t attend in real time

Plenary Keynote from Thought Leaders sharing big-picture perspectives on “hot” targets and technologies for the discovery of novel therapeutics

In-depth, instructional, virtual Short Courses

Brainstorming Interactive Discussions

1-on-1 Networking

Our Drug Discovery Community: Engage with technology and business attendees ready for networking and mutual learning in-person and across time zones

Poster presentations sharing a stimulating spectrum of research

Exhibiting and sponsoring companies revealing solutions to persistent challenges